The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Identification of SLC25A46 interaction interfaces with mitochondrial membrane fusogens Opa1 and Mfn2
Open accessPublished version of a preprint
Abstract
Mitochondrial fusion requires the sequential merger of four bilayers to two. The outer-membrane solute carrier protein SLC25A46 interacts with both the outer and inner-membrane dynamin family GTPases Mfn1/2 and Opa1. While SLC25A46 levels are known to affect mitochondrial morphology, how SLC25A46 interacts with Mfn1/2 and Opa1 to regulate membrane fusion is not understood. In this study, we use crosslinking mass-spectrometry and AlphaFold 2 modeling to identify interfaces mediating a SLC25A46 interactions with Opa1 and Mfn2. We reveal that the bundle signaling element of Opa1 interacts with SLC25A46, and present evidence of a Mfn2 interaction involving the SLC25A46 cytosolic face. We validate these newly identified interaction interfaces and show that they play a role in mitochondrial network maintenance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Flagged first, then by citations
Research works printed but not linked: 60
- Wai, 2016, Mitochondrial dynamics and metabolic regulation, Trends Endocrinol. Metab., 27, 105, 10.1016/j.tem.2015.12.001 · DOI
- Yapa, 2021, Mitochondrial dynamics in health and disease, FEBS Lett., 595, 1184, 10.1002/1873-3468.14077 · DOI
- Giacomello, 2020, The cell biology of mitochondrial membrane dynamics, Nat. Rev. Mol. Cell Biol., 21, 204, 10.1038/s41580-020-0210-7 · DOI · Paper page
- Chan, 2020, Mitochondrial dynamics and its involvement in disease, Annu. Rev. Pathol., 15, 235, 10.1146/annurev-pathmechdis-012419-032711 · DOI · Paper page
- Meyer, 2017, Mitochondrial fusion, fission, and mitochondrial toxicity, Toxicology, 391, 42, 10.1016/j.tox.2017.07.019 · DOI
- Janer, 2016, SLC25A46 is required for mitochondrial lipid homeostasis and cristae maintenance and is responsible for Leigh syndrome, EMBO Mol. Med., 8, 1019, 10.15252/emmm.201506159 · DOI
- Perivolidi, 2022, Proteomic identification of the SLC25A46 interactome in transgenic mice expressing slc25a46-FLAG, J. Proteome Res., 21, 375, 10.1021/acs.jproteome.1c00728 · DOI
- Schuettpelz, 2023, The role of the mitochondrial outer membrane protein SLC25A46 in mitochondrial fission and fusion, Life Sci. Alliance, 6, 10.26508/lsa.202301914 · DOI
- Steffen, 2017, Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria, Mol. Biol. Cell, 28, 600, 10.1091/mbc.e16-07-0545 · DOI
- Kunji, 2020, The SLC25 carrier family: important transport proteins in mitochondrial physiology and pathology, Physiology (Bethesda), 35, 302
- Kodal, 2022, Case report: a novel variant in SLC25A46 causing sensorimotor polyneuropathy and optic atrophy, Front Neurol., 13, 10.3389/fneur.2022.1066040 · DOI
- Yamada, 2022, Diagnosis of SLC25A46-related pontocerebellar hypoplasia in two siblings with fulminant neonatal course: role of postmortem CT and whole genomic analysis: a case report, BMC Neurol., 22, 20, 10.1186/s12883-021-02540-x · DOI
- Li, 2021, Reanalysis of exome data identifies novel SLC25A46 variants associated with Leigh syndrome, J. Pers Med., 11
- Raju, 2021, Dystonia and hereditary motor sensory neuropathy 6B due to SLC25A46 gene mutations, Mov Disord. Clin. Pract., 8, 480, 10.1002/mdc3.13139 · DOI
- Bitetto, 2020, SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy, Parkinsonism Relat. Disord., 74, 1, 10.1016/j.parkreldis.2020.03.018 · DOI
- Abrams, 2018, Insights into the genotype-phenotype correlation and molecular function of SLC25A46, Hum. Mutat., 39, 1995, 10.1002/humu.23639 · DOI
- Ivanov, 2018, Pontocerebellar hypoplasia type 1 for the neuropediatrician: genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature, Eur. J. Paediatr. Neurol., 22, 674, 10.1016/j.ejpn.2018.03.011 · DOI
- Braunisch, 2018, Extension of the phenotype of biallelic loss-of-function mutations in SLC25A46 to the severe form of pontocerebellar hypoplasia type I, Clin. Genet., 93, 255, 10.1111/cge.13084 · DOI
- van Dijk, 2017, Pontocerebellar hypoplasia with spinal muscular atrophy (PCH1): identification of SLC25A46 mutations in the original Dutch PCH1 family, Brain, 140, 10.1093/brain/awx147 · DOI
- Hammer, 2017, SLC25A46 mutations associated with autosomal recessive cerebellar ataxia in north african families, Neurodegener Dis., 17, 208, 10.1159/000464445 · DOI
- Sulaiman, 2017, A novel mutation in SLC25A46 causes optic atrophy and progressive limb spasticity, with no cerebellar atrophy or axonal neuropathy, Clin. Genet., 92, 230, 10.1111/cge.12963 · DOI
- Wan, 2016, Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia, Brain, 139, 2877, 10.1093/brain/aww212 · DOI
- Charlesworth, 2016, SLC25A46 mutations underlie progressive myoclonic ataxia with optic atrophy and neuropathy, Mov Disord., 31, 1249, 10.1002/mds.26716 · DOI
- Nguyen, 2017, Novel pathogenic SLC25A46 splice-site mutation causes an optic atrophy spectrum disorder, Clin. Genet., 91, 121, 10.1111/cge.12774 · DOI
- Abrams, 2015, Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder, Nat. Genet., 47, 926, 10.1038/ng.3354 · DOI
- Duchesne, 2017, Bovine and murine models highlight novel roles for SLC25A46 in mitochondrial dynamics and metabolism, with implications for human and animal health, PLoS Genet., 13, 10.1371/journal.pgen.1006597 · DOI
- Li, 2017, Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice, Hum. Mol. Genet., 26, 3776, 10.1093/hmg/ddx262 · DOI
- Suda, 2018, Novel Drosophila model for mitochondrial diseases by targeting of a solute carrier protein SLC25A46, Brain Res., 1689, 30, 10.1016/j.brainres.2018.03.028 · DOI
- Terzenidou, 2017, Novel insights into SLC25A46-related pathologies in a genetic mouse model, PLoS Genet., 13, 10.1371/journal.pgen.1006656 · DOI
- Qiu, 2022, Light-activated mitochondrial fission through optogenetic control of mitochondria-lysosome contacts, Nat. Commun., 13, 4303, 10.1038/s41467-022-31970-5 · DOI
- Santo-Domingo, 2023, SLC25A46 promotes mitochondrial fission and mediates resistance to lipotoxic stress in INS-1E insulin-secreting cells, J. Cell Sci., 136, 10.1242/jcs.260049 · DOI
- Coonrod, 2007, Ugo1p is a multipass transmembrane protein with a single carrier domain required for mitochondrial fusion, Traffic, 8, 500, 10.1111/j.1600-0854.2007.00550.x · DOI
- Sesaki, 2001, UGO1 encodes an outer membrane protein required for mitochondrial fusion, J. Cell Biol., 152, 1123, 10.1083/jcb.152.6.1123 · DOI
- Sesaki, 2004, Ugo1p links the Fzo1p and Mgm1p GTPases for mitochondrial fusion, J. Biol. Chem., 279, 28298, 10.1074/jbc.M401363200 · DOI
- Hoppins, 2009, Mitochondrial outer and inner membrane fusion requires a modified carrier protein, J. Cell Biol., 184, 569, 10.1083/jcb.200809099 · DOI
- Sesaki, 2003, Mgm1p, a dynamin-related GTPase, is essential for fusion of the mitochondrial outer membrane, Mol. Biol. Cell, 14, 2342, 10.1091/mbc.e02-12-0788 · DOI
- Wong, 2003, The intramitochondrial dynamin-related GTPase, Mgm1p, is a component of a protein complex that mediates mitochondrial fusion, J. Cell Biol., 160, 303, 10.1083/jcb.200209015 · DOI
- Mirdita, 2022, ColabFold: making protein folding accessible to all, Nat. Methods, 19, 679, 10.1038/s41592-022-01488-1 · DOI · Paper page
- Ishihara, 2006, Regulation of mitochondrial morphology through proteolytic cleavage of OPA1, EMBO J., 25, 2966, 10.1038/sj.emboj.7601184 · DOI · Paper page
- Olichon, 2002, The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space, FEBS Lett., 523, 171, 10.1016/S0014-5793(02)02985-X · DOI
- Chappie, 2009, An intramolecular signaling element that modulates dynamin function in vitro and in vivo, Mol. Biol. Cell, 20, 3561, 10.1091/mbc.e09-04-0318 · DOI
- Sever, 1999, Impairment of dynamin's GAP domain stimulates receptor-mediated endocytosis, Nature, 398, 481, 10.1038/19024 · DOI
- Anand, 2016, Crystal structure of the GTPase domain and the bundle signalling element of dynamin in the GDP state, Biochem. Biophys. Res. Commun., 469, 76, 10.1016/j.bbrc.2015.11.074 · DOI
- Chappie, 2010, G domain dimerization controls dynamin's assembly-stimulated GTPase activity, Nature, 465, 435, 10.1038/nature09032 · DOI
- Kong, 2018, Cryo-EM of the dynamin polymer assembled on lipid membrane, Nature, 560, 258, 10.1038/s41586-018-0378-6 · DOI
- Li, 2019, Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset, Nat. Commun., 10, 4914, 10.1038/s41467-019-12912-0 · DOI
- Labbe, 2021, The modified mitochondrial outer membrane carrier MTCH2 links mitochondrial fusion to lipogenesis, J. Cell Biol, 220, 10.1083/jcb.202103122 · DOI
- Tondera, 2009, SLP-2 is required for stress-induced mitochondrial hyperfusion, EMBO J., 28, 1589, 10.1038/emboj.2009.89 · DOI
- Gao, 2021, Mitochondrial fusion: the machineries in and out, Trends Cell Biol., 31, 62, 10.1016/j.tcb.2020.09.008 · DOI
- Anand, 2014, The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission, J. Cell Biol., 204, 919, 10.1083/jcb.201308006 · DOI · Paper page
- Ban, 2017, Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin, Nat. Cell Biol., 19, 856, 10.1038/ncb3560 · DOI · Paper page
- Ge, 2020, Two forms of Opa1 cooperate to complete fusion of the mitochondrial inner-membrane, Elife, 9, 10.7554/eLife.50973 · DOI · Paper page
- Mishra, 2014, Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation, Cell Metab., 19, 630, 10.1016/j.cmet.2014.03.011 · DOI · Paper page
- Schuettpelz, 2024, SLC25A46 Is in Contact with Lysosomes and Plays a Role in Mitochondrial Cholesterol Homeostasis, bioRxiv
- Faelber, 2019, Structure and assembly of the mitochondrial membrane remodelling GTPase Mgm1, Nature, 571, 429, 10.1038/s41586-019-1372-3 · DOI
- Nyenhuis, 2023, OPA1 helical structures give perspective to mitochondrial dysfunction, Nature, 620, 1109, 10.1038/s41586-023-06462-1 · DOI
- von der Malsburg, 2023, Structural mechanism of mitochondrial membrane remodelling by human OPA1, Nature, 620, 1101, 10.1038/s41586-023-06441-6 · DOI
- Hartmann, 2016, Expression of eukaryotic membrane proteins in Pichia pastoris, Methods Mol. Biol., 1432, 143, 10.1007/978-1-4939-3637-3_10 · DOI
- Wang, 2021, Identification of new OPA1 cleavage site reveals that short isoforms regulate mitochondrial fusion, Mol. Biol. Cell, 32, 157, 10.1091/mbc.E20-09-0605 · DOI
- Schindelin, 2012, Fiji: an open-source platform for biological-image analysis, Nat. Methods, 9, 676, 10.1038/nmeth.2019 · DOI · Paper page
Metadata
- Authors
- Boopathy, S., Luce, B. E., Lugo, C. M., Hakim, P., McDonald, J., Kim, H. L., Ponce, J., Ueberheide, B. M., & Chao, L. H.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- NYU Langone Health (US)
- Corresponding author
- Chao, Luke H.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2024-10
- Volume
- 300
- Issue
- 10
- Pages
- 107740
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC11459905
- OpenAlex
- W4402083452
- Cited by
- 14
- References
- 1
- Citations by year
- 2026: 5 · 2025: 9
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Funders
- National Institutes of Health (1S10OD010582-01A1)
- NIGMS (R35GM142553)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
- Keywords
- SLC25A46, OPA1, mitofusin 2, mitochondrial fusion, protein-protein interfaces, mitochondrial membrane, mitochondrial morphology, cross-linking mass spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review